From: Structure and activation of the TSH receptor transmembrane domain
Receptor | Species | PDB-Id | State | Resolution | TMD identitya (%) | Used for the modelling of | References | ||
---|---|---|---|---|---|---|---|---|---|
TMD_I | TMD_In | TMD_Ac | |||||||
CXC chemokine receptor type 1 | Human | 2LNL | Inactive | NMR | 20.7 | ✓ | ✖ | ✖ | [50] |
β1-Adrenergic receptor | Turkey | 2VT4 | Inactive | 2.7 Å | 18.4 | ✓ | ✖ | ✖ | [51] |
Rhodopsin | Squid | 2Z73 | Inactive | 2.50 Å | 17.6 | ✓ | ✖ | ✖ | [52] |
Adenosine A2A receptor | Human | 3EML | Inactive | 2.60 Å | 21.0 | ✓ | ✖ | ✖ | [53] |
CXC chemokine receptor type 4 | Human | 3ODU | Inactive | 2.50 Å | 19.5 | ✓ | ✖ | ✖ | [54] |
Histamine H1 receptor | Human | 3RZE | Inactive | 3.10 Å | 18.0 | ✓ | ✖ | ✖ | [55] |
Sphingosine 1-phosphate receptor 1 | Human | 3V2Y | Inactive | 2.80 Å | 17.5 | ✓ | ✖ | ✖ | [56] |
Proteinase-activated receptor 1 | Human | 3VW7 | Inactive | 2.20 Å | 17.6 | ✓ | ✖ | ✖ | [57] |
M3 muscarinic acetylcholine receptor | Rat | 4DAJ | Inactive | 3.40 Å | 20.5 | ✓ | ✖ | ✖ | [58] |
κ-Opioid receptor | Human | 4DJH | Inactive | 2.90 Å | 18.0 | ✓ | ✖ | ✖ | [59] |
μ-Opioid receptor | Mouse | 4DKL | Inactive | 2.80 Å | 18.8 | ✓ | ✖ | ✖ | [60] |
Nociceptin/orphanin FQ receptor | Human | 4EA3 | Inactive | 3.01 Å | 20.7 | ✓ | ✖ | ✖ | [61] |
δ-Opioid receptor | Mouse | 4EJ4 | Inactive | 3.40 Å | 20.0 | ✓ | ✖ | ✖ | [62] |
Rhodopsin | Bovine | 1U19 | Inactive | 2.20 Å | 17.7 | ✓ | ✓ | ✖ | [22] |
β2-Adrenergic receptor | Human | 2RH1 | Inactive | 2.40 Å | 21.4 | ✓ | ✓ | ✖ | [23] |
M2 muscarinic acetylcholine receptor | Human | 3UON | Inactive | 3.00 Å | 19.7 | ✓ | ✓ | ✖ | [24] |
Metarhodopsin II | Bovine | 3PQR | Active | 2.85 Å | 17.7 | ✖ | ✖ | ✓ | [19] |
β2-Adrenergic receptor-Gs protein complex | Human | 3SN6 | Active | 3.20 Å | 21.4 | ✖ | ✖ | ✓ | [20] |
M2 muscarinic acetylcholine receptor | Human | 4MQS | Active | 3.50 Å | 17.7 | ✖ | ✖ | ✓ | [21] |
Smoothened receptor | Human | 4LKV | Inactive | 2.45 Å | – | ECL-1 | [63] |